Potential Effectiveness of Hydroxychloroquine Drugs to Treat Covid-19 to Drive Global Demand

The demand within the global hydroxychloroquine drugs market is expected to increase in the times to follow. The past few weeks have witnessed several rounds of discussions about this drug across the medical fraternity. The traditional usage of this drug is linked to treatment of rheumatoid arthritis, malaria, and lupus erythematosus.  Research related to these diseases and disorders has gained momentum in recent times. The medical industry is leaving no stone unturned in trying to develop a robust pathway for treating common diseases. Furthermore, the past few years have witnessed improved collaboration between healthcare professionals and medical researchers. The responsiveness of medical researchers and analysts to resolve the unmet needs of the healthcare sector has become the basis for market growth.

In the contemporary times, the value of the global hydroxychloroquine drugs market is defined by the volume of usage of this drug across the medical sector. In this review, several factors pertaining to the usage and sale of hydroxychloroquine drugs have been enunciated. The presence of an expansive research fraternity that tests, analyses, and grades various drug classes shall aid market maturity. In addition to this, export and import dynamics of regions shall also play defining role in driving sales across the global hydroxychloroquine drugs market. The regional dynamics of market growth have been elucidated herein. There is utmost regard for medical research across developed countries, and this trend is gaining more prominence in recent times.

Role of FDA in Drug Approval

Drug development has emerged as a crucial contributor to advancements in modern medicine. Several drug classes have been tested over the past decade, creating a playfield to develop new treatment lines. It is legit to expect that the global hydroxychloroquine drugs market would tread along a lucrative trajectory in the times to follow. Furthermore, the quest of the medical industry to popularise novel drugs has also aided market growth. The Food and Drug Administration (FDA) of the US has helped several drug manufacturers in gaining prominence across the medical sector. FDA is responsible for approving newly developed drug classes, preceded by rigorous testing and analysis. The FDA also releases information about dosage levels and possible side effects of newly developed drugs. It is safe to assert that the FDA has played a vital role in driving demand within the global hydroxychloroquine drugs market.

Outbreak of the Covid-19 Pandemic

The Covid-19 pandemic was declared as a global health emergency by the WHO in early January, this early. This announcement was followed by extensive research and testing to develop effective vaccines against the coronavirus. Several countries vested their healthcare and research fraternities towards development of novel treatment lines for covid-19. The use of hydroxychloroquine drugs during the course of such researches has been particularly intriguing. Therefore, it is safe to expect that the global hydroxychloroquine drugs market would grow at a sturdy pace in the years to follow. The United States Center for Disease Control provides valuable information about the importance of hydroxychloroquine drugs in the medical industry.

Supply of Hydroxychloroquine from India to the US

The recent retrieval of supplies for hydroxychloroquine by the US from India created a stir across the global market. India had pulled back its supply of hydroxychloroquine to the US for a temporary phase. However, to maintain its diplomatic ties with the US and on the call of the US President, India restarted its supply operations to the US. India is amongst the largest producers of hydroxychloroquine, and the recent move by the country shall cause formidable disruptions across the market.

Some of the leading vendors operating in the global hydroxychloroquine drugs market are Sanofi S.A., Novartis International AG, Amneal Pharmaceuticals, Inc., Prasco Laboratories, Laurus Labs Limited, and Cardinal Health. 

7 of 10 large enterprizes view our ToC to take the right decision.

Get In Touch